# FDA Inspection 1190311 - Mid-South Transplant Foundation - October 26, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/mid-south-transplant-foundation/f6ea1b60-e3d7-4112-8121-7b22c42d0db7/
Source feed: FDA_Inspections

> FDA Inspection 1190311 for Mid-South Transplant Foundation on October 26, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1190311
- Company Name: Mid-South Transplant Foundation
- Inspection Date: 2022-10-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1303560 - 2026-02-06](https://www.globalkeysolutions.net/api/records/fda_inspections/mid-south-transplant-foundation/30b3a715-189f-4592-853c-8456cb640a7d/)
- [FDA Inspection 1303560 - 2026-02-06](https://www.globalkeysolutions.net/api/records/fda_inspections/mid-south-transplant-foundation/22af957e-ebbb-4b6d-8d52-8bb5eafd6607/)
- [FDA Inspection 1190311 - 2022-10-26](https://www.globalkeysolutions.net/api/records/fda_inspections/mid-south-transplant-foundation/f5f829e3-fcb5-4f9f-8fce-476a215a8296/)
- [FDA Inspection 1190311 - 2022-10-26](https://www.globalkeysolutions.net/api/records/fda_inspections/mid-south-transplant-foundation/fd39b20b-fe03-4abf-9ca4-ce5454b8d7ee/)
- [FDA Inspection 1079953 - 2019-02-07](https://www.globalkeysolutions.net/api/records/fda_inspections/mid-south-transplant-foundation/6e4ef2df-5339-4b4a-80bb-efe755adc2a5/)

Company: https://www.globalkeysolutions.net/companies/mid-south-transplant-foundation/322c149a-44d0-447c-9465-6f1f53ef9bbe

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d